Table 3 Comparison of SLC5A8 gene methylation in patients with different clinical features in baseline
From: Role of hypermethylated SLC5A8 in follicular thyroid cancer diagnosis and prognosis prediction
Variables | n | Positive (n = 92) | Negative (n = 73) | χ2 | P |
|---|---|---|---|---|---|
Age | |||||
< 45 | 110 | 59(53.6) | 51(46.4) | 0.602 | 0.438 |
≥ 45 | 55 | 33(60.0) | 22(40.0) | ||
Sex | |||||
Male | 74 | 42(56.8) | 32(43.2) | 0.054 | 0.816 |
Female | 91 | 50(54.9) | 41(45.1) | ||
Tumor size | |||||
< 1.0 cm | 71 | 41(57.7) | 30(42.3) | 0.200 | 0.655 |
≥ 1.0 cm | 94 | 51(54.3) | 43(45.7) | ||
TG | |||||
< 40 μg/L | 91 | 42(46.2) | 49(53.8) | 7.586 | 0.006 |
≥ 40 μg/L | 74 | 50(67.6) | 24(32.4) | ||
Chol | |||||
< 5.17 mmol/L | 114 | 57(50.0) | 57(50.0) | 4.956 | 0.026 |
≥ 5.17 mmol/L | 51 | 35(68.6) | 16(31.4) | ||
Triglycerides | |||||
< 1.7 mmol/L | 134 | 73(54.5) | 61(45.5) | 0.474 | 0.491 |
≥ 1.7 mmol/L | 31 | 19(61.3) | 12(38.7) | ||
Pathological type | |||||
FTC | 58 | 42(72.4) | 16 (27.6) | 13.063 | 0.001 |
FTA | 67 | 27(40.3) | 40 (59.7) | ||
TT-UMP | 40 | 23(57.5) | 17 (42.5) | ||